Generation of induced pluripotent stem cell line from a patient with long COVID

David Wu1, Amit Manhas2, Chikage Noishiki1

  • 1Stanford Cardiovascular Institute, Stanford University School of Medicine, CA, USA; Division of Vascular Surgery, Department of Surgery, Stanford University School of Medicine, CA, USA.

Stem Cell Research
|January 17, 2025
PubMed

Insights

Long COVID causes vascular dysfunction and increased clotting risk. Researchers created a stem cell line from a patient to study these long-term effects and multi-organ damage.

Area of Science:

  • Stem cell biology
  • Infectious disease research
  • Vascular medicine

Background:

  • Long COVID, or post-acute sequelae of SARS-CoV-2 infection, is linked to vascular dysfunction and multi-organ damage.
  • COVID-19-associated coagulopathy (CAC) signifies an increased thrombotic risk in Long COVID patients.
  • Understanding the mechanisms of Long COVID is crucial for developing effective treatments.

Purpose of the Study:

  • To derive and characterize a human induced pluripotent stem cell (iPSC) line from a Long COVID patient.
  • To establish a cellular model for investigating the pathogenesis of Long COVID.
  • To facilitate research into the vascular and multi-organ complications associated with SARS-CoV-2 infection.

Main Methods:

  • Peripheral blood mononuclear cells (PBMCs) were collected from a Long COVID patient.
  • PBMCs were reprogrammed into induced pluripotent stem cells (iPSCs).
  • The derived iPSC line was characterized for morphology, pluripotency, karyotype stability, and differentiation potential.

Main Results:

  • A stable iPSC line was successfully derived from a Long COVID patient.
  • The iPSC line exhibited normal morphology and maintained pluripotency.
  • The iPSC line demonstrated successful differentiation into ectoderm, endoderm, and mesoderm germ layers.

Conclusions:

  • The established iPSC line serves as a valuable tool for modeling Long COVID.
  • This cellular model can aid in exploring the mechanisms of vascular dysfunction and multi-organ damage in Long COVID.
  • Further research using this iPSC line may uncover novel therapeutic strategies for Long COVID complications.

Related Concept Videos

Induced Pluripotent Stem Cells01:06

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
3.9K
EPS and iPS Cells in Disease Research01:21

EPS and iPS Cells in Disease Research

Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...
2.8K
iPS Cell Differentiation01:22

iPS Cell Differentiation

The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
2.6K